HepG2 |
Function assay |
1 uM |
18 hrs |
Decrease in CYP7A1 gene expression in human HepG2 cells at 1 uM after 18 hrs by RT-PCR |
17963371 |
Caco-2 |
Function assay |
1 uM |
6 days |
Activation of IBABP gene expression in human Caco-2 cells at 1 uM after 6 days by RT-PCR |
17963371 |
HepG2 |
Function assay |
1 uM |
18 hrs |
Activation of BSEP gene expression in human HepG2 cells at 1 uM after 18 hrs by RT-PCR |
17963371 |
Huh7 |
Function assay |
1 uM |
18 hrs |
Activation of SHP gene expression in human Huh7 cells at 1 uM after 18 hrs by RT-PCR |
17963371 |
Huh7 |
Function assay |
1 uM |
18 hrs |
Activation of BSEP gene expression in human Huh7 cells at 1 uM after 18 hrs by RT-PCR |
17963371 |
HepG2 |
Function assay |
10 uM |
10 mins |
Induction of FXR-mediated Akt-phosphorylation at S473 site in serum-starved human HepG2 cells at 10 uM measured after 10 mins by western blot analysis |
27372840 |
HepG2 |
Function assay |
10 uM |
10 mins |
Induction of FXR-mediated Akt-phosphorylation in serum-starved human HepG2 cells assessed as increase in GSK-3beta-phosphorylation at 10 uM measured after 10 mins by western blot analysis |
27372840 |
HepG2 |
Function assay |
10 uM |
|
Induction of FXR-mediated SHP mRNA expression in serum-starved human HepG2 cells at 10 uM measured after overnight incubation by qPCR analysis |
27372840 |
HepG2 |
Function assay |
10 uM |
|
Activation of FXR in human HepG2 cells assessed as upregulation of SHP mRNA expression at 10 uM by RT-PCR method |
30031618 |
HepG2 |
Function assay |
10 uM |
|
Activation of FXR in human HepG2 cells assessed as upregulation of FXR mRNA expression at 10 uM by RT-PCR method |
30031618 |
HepG2 |
Function assay |
10 uM |
|
Activation of FXR in human HepG2 cells assessed as downregulation of SREBP-1c mRNA expression at 10 uM by RT-PCR method |
30031618 |
3T3L1 |
Function assay |
10 uM |
|
Reduction in lipid accumulation in mouse 3T3L1 cells at 10 uM by Oil Red O staining-based absorbance method relative to control |
30342957 |
HeLa |
Function assay |
|
24 hrs |
Agonist activity at human full length FXR expressed in HeLa cells cotransfected with pSG5-human RXR after 24 hrs by Dual-Glo luciferase reporter gene assay, EC50 = 0.51 μM. |
25934227 |
insect cells |
Function assay |
|
1 hr |
Agonist activity at recombinant human GST-tagged FXR ligand binding domain (193 to 472 residues) expressed in baculovirus infected insect cells assessed as induction of interaction with biotin labelled SRC-1 after 1 hr by HTRF assay, EC50 = 0.019 μM. |
29148806 |
HEK293T |
Function assay |
|
24 hrs |
Agonist activity at human FXR expressed in HEK293T cells assessed as BSEP promoter driven cellular transcriptional activity after 24 hrs by luciferase reporter gene assay, EC50 = 0.095 μM. |
29148806 |
HEK293 |
Function assay |
|
|
Agonist activity at human GST-fused FXR LBD expressed in HEK293 cells coexpressing GAL4-DNA bindig domain and pFRluc by mammalian one-hybrid assay, EC50 = 0.035 μM. |
20638278 |
HEK293 |
Function assay |
|
|
Agonist activity at human full length FXR transfected in HEK293 cells coexpressing pTRexDest/pGL2promotor assessed as luciferase activity by direct reporter cellular assay, EC50 = 0.03 μM. |
20638278 |
CV1 |
Function assay |
|
|
Increase in human FXR-mediated transient transcription of luciferase reporter gene transfected in african green monkey CV1 cells, EC50 = 0.065 μM. |
19586769 |
CV1 |
Function assay |
|
|
Agonist activity at human FXR transfected in african green monkey CV1 cells by luciferase reporter gene transient transfection assay, EC50 = 0.065 μM. |
19410460 |
CV1 |
Function assay |
|
|
Agonist activity at FXR expressed in african green monkey CV1 cells by luciferase reporter transient transfection assay, EC50 = 0.065 μM. |
18621523 |
HEK293 |
Function assay |
|
|
Agonistic activity at FXR in HEK293 cells by GAL4 transactivation activity, EC50 = 0.07 μM. |
17292610 |
CV-1 |
Function assay |
|
|
Agonist activity at human FXR LBD iexpressed in monkey CV-1 cells assessed as transactivation of luciferase reporter gene expression, EC50 = 0.065 μM. |
21256005 |
CV1 |
Function assay |
|
|
Agonist activity at human FXR LBD transfected in african green monkey CV1 cells after overnight incubation by luciferase reporter gene assay, EC50 = 0.065 μM. |
21890356 |
HEK293 |
Function assay |
|
|
Agonist activity at human recombinant FXR expressed in HEK293 cells coexpressing CMX-GAL4N by luciferase reporter gene assay, EC50 = 0.07 μM. |
22583617 |
HEK293 |
Function assay |
|
|
Agonist activity at human FXR expressed in HEK293 cells by luciferase reporter gene assay, EC50 = 0.026 μM. |
25305688 |
CV1 |
Function assay |
|
|
Agonist activity at FXR (unknown origin) transfected into african green monkey CV1 cells assessed as ligand-mediated transcription by luciferase reporter/ transient transfection assay, EC50 = 0.065 μM. |
25499883 |
HEK293 |
Function assay |
|
|
Agonist activity at human FXR transfected in HEK293 cells assessed as transcriptional activity by luciferase reporter gene assay, EC50 = 0.373 μM. |
26568144 |
HEK-293 |
Function assay |
|
|
Agonist activity at C-terminal Gal4-tagged human FXR (187 to 472 residues) expressed in HEK-293 cells co-expressing pFRluc by mammalian one hybrid assay, EC50 = 0.035 μM. |
27268696 |